Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Cogito Ergo Sum who wrote (174464)	7/8/2021 7:40:43 AM
From: TobagoJack	1 Recommendation Recommended By marcher Read Replies (3) \| Respond to of 217709

It would seem Trump’s enemies are not yet done with him Donald Trump praised Adolf Hitler on Europe trip, book claims scmp.com In the meantime business conditions seem bullish … bloomberg.com 229% Surge in China-U.S. Shipping Costs Drives Inflation Pressure Brendan Murray July 8, 2021, 7:21 PM GMT+8 The cost to ship a boxload of goods to the U.S. from China edged close to $10,000 as the world’s biggest economy keeps vacuuming up imports amid slower recoveries from the pandemic from Europe to Asia. The spot rate for a 40-foot container from Shanghai to Los Angeles increased to $9,631, up 5% from the previous week and 229% higher than a year ago, according to the Drewry World Container Index publishedThursday. A composite index, reflecting eight major trade routes, rose to $8,796, a 333% surge from a year ago. Drewry said it expects rates to increase further in the coming week. Uncontainable Shipping costs to the U.S. are closing in on $10,000 per box Drewry While the surging rates represent a profit bonanza for container lines including Copenhagen-based A.P. Moller-Maersk A/S and China’s Cosco Shipping Holdings Co., they’re making it more difficult for importers to absorb higher costs. Some are raising retail prices, adding to inflationary pressures that worry central banks, while Covid-related supply bottlenecks are also holding back economic activity. U.S. Trade Deficit Increased to Second Biggest on Record in May The cost for a container from Shanghai to Rotterdam passed the $10,000 threshold in late May and has continued to rise. It reached $12,795 this week, according to Drewry. That’s up nearly 600% from a year ago. Unthinkable Rates The prospect of $10,000-a-box charges for the busy Asia-to-U.S. route would’ve been unthinkable to most shipping analysts before the pandemic. The average rate for shipping from Shanghai to Los Angeles was less than $1,800 per container from 2011 to March 2020, Drewry data show. While demand from American consumers and companies is one reason for the rate spike, a shortage of containers remains another reason for the tight market. Container capacity is particularly scarce for eastbound transpacific shipments, with Covid outbreaks at a port in southern China recently snarling both exports and imports. Meanwhile, a queue of vessels waiting to enter the twin ports of Los Angeles and Long Beach, California -- the largest U.S. gateway for ocean-going trade -- showed little signs of going away. The number of container ships anchored in San Pedro Bay totaled 18 as of late Tuesday, nearly double the queue of two weeks earlier, according to officials who monitor harbor traffic. That bottleneck has persisted since late last year, peaking around 40 vessels in early February. The average wait for berth space was 5.3 days, compared with 4.6 in early June, according to the L.A. port. That number peaked around 8 days in April. Before it's here, it's on the Bloomberg Terminal. LEARN MORE Sent from my iPad

To: Cogito Ergo Sum who wrote (174464)

7/8/2021 7:45:52 AM

From: TobagoJack

1 Recommendation

Recommended By
marcher

Read Replies (2) | Respond to of 217709

I noticed, and did not take acumen, that ‘they’, the usual suspects, did not tell us how many people died from which vaccine, even as overall birth vaccines are effectively even, since not-catching-the-virus is no longer the name of the variant game

bloomberg.com

Sinovac’s Vaccine Found Inferior to Pfizer Shot in Chile Study

Jason Gale
July 8, 2021, 9:17 AM GMT+8
Sinovac Biotech Ltd.’s vaccine was less potent than Pfizer Inc.’s shot at stopping Covid-19 in Chile where the two shots were used simultaneously, the first real-world analysis comparing a China-made inoculation against an mRNA has found.

Researchers found CoronaVac was 66% effective in preventing Covid-19 among fully vaccinated adults, versus 93% for the jab made by Pfizer and its partner BioNTech SE.

The inactivated inoculation, given to more than 10 million Chileans, was slightly less effective in preventing hospitalization and deaths than the mRNA vaccine, which was administered to fewer than half a million people, according to the study, published Wednesday in the New England Journal of Medicine.

The research was conducted from February through May, when the alpha and gamma strains of the virus were the variants of concern most frequently detected in Chile. Preliminary data released in April found CoronaVac was 67% effective in preventing symptomatic Covid-19 infections and warded off 80% of fatalities from the disease.

The final results suggest CoronaVac, the mainstay of Chile’s vaccination strategy, provides an effective shield against Covid-19, including severe disease, consistent with the results of mid-stage trials, the authors said.

As of May 10, Chile’s Ministry of Health has administered almost 14 million CoronaVac doses, including enough to fully immunize 6.36 million people. In comparison, 2.4 million doses of the Pfizer-BioNTech vaccine had been administered. Individuals 16 years or older are eligible to be immunized, according to the national vaccination schedule.

Comparative effectiveness data are given below:

Covid-19HospitalizationICU admissionDeath

CoronaVac	65.9%	87.5%	90.3%	86.3%
Pfizer-BioNTech	92.6%	95.1%	96.2%	91.0%

The study was funded by Chile’s National Research and Development Agency.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE

Sent from my iPad